Jessica Hill
Adult Health · Phoenix, AZNPI 1992579759
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,901 of the $7,213 with a category attached, or 81.8%. 40 manufacturers reported payments, led by Abbott at 29.5% of the total. 2025 is the largest year on record at $5,152, more than ten times the $196 reported in 2023. Among adult health clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 290 payments — averaging $24.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- AbbVie$1K
- UCB, Inc.$405
- Lilly USA, LLC$319
- Eisai Inc.$292
- Argenx US, Inc.$286
- plus $3K from 34 others
What the payments were for
- Travel & lodging$1,31218%
- Food & beverage$5,90182%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 18 | $2,127 |
| AbbVie | 89 | $1,267 |
| UCB, Inc. | 28 | $405 |
| Lilly USA, LLC | 17 | $319 |
| Eisai Inc. | 12 | $292 |
| Argenx US, Inc. | 11 | $286 |
| Neurocrine Biosciences, Inc. | 8 | $189 |
| Amneal Pharmaceuticals LLC | 10 | $176 |
| Biogen | 11 | $171 |
| Pfizer | 8 | $155 |
| Genentech USA, Inc. | 5 | $146 |
| EMD Serono, Inc. | 9 | $141 |
| SK Life Science, Inc. | 5 | $130 |
| Otsuka America Pharmaceutical, Inc. | 2 | $128 |
| Medtronic | 1 | $113 |
| Merz Pharmaceuticals, LLC | 4 | $98 |
| AstraZeneca | 4 | $97 |
| Vanda Pharmaceuticals Inc. | 3 | $95 |
| TG Therapeutics, Inc. | 5 | $91 |
| Impel Pharmaceuticals LLC | 3 | $80 |
| Lundbeck LLC | 4 | $76 |
| Neurelis, Inc. | 5 | $75 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| Acadia Pharmaceuticals Inc | 3 | $60 |
| Banner Life Sciences, LLC | 3 | $58 |
| Novartis | 3 | $57 |
| Mallinckrodt Hospital Products Inc. | 2 | $44 |
| CSL Behring | 1 | $35 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Sanofi | 1 | $27 |
| Catalyst Pharmaceuticals, Inc. | 1 | $25 |
| Amgen | 1 | $24 |
| Tonix Medicines, Inc. | 1 | $19 |
| Harmony Biosciences LLC | 1 | $18 |
| Cycle Pharmaceuticals Inc | 1 | $18 |
| Springworks Therapeutics, Inc. | 1 | $16 |
| Cala Health, Inc. | 1 | $15 |
| Foundation Fusion Solutions, LLC | 1 | $15 |
| Boston Scientific | 1 | $13 |
| Aucta Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$1,571
- PROCLAIM$232
- BOTOX$125
- PERCEPT PC BRAINSENSE$113
How this compares
$7,213 in reported general payments places this provider in the 90th percentile of 314 adult health providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 11 | $14,131 |
| Memantine Hcl | 80 | $2,158 |
| Pregabalin | 60 | $1,556 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 23 | $1,533 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 36 | $1,526 |
| Gabapentin | 60 | $1,305 |
| Primidone | 27 | $1,128 |
| Donepezil Hcl | 130 | $1,074 |
| Amitriptyline Hcl | 49 | $995 |
| Propranolol Hcl | 25 | $826 |
| Duloxetine Hcl | 23 | $789 |
| Levetiracetam | 22 | $647 |
| Fluoxetine Hcl | 12 | $515 |
| Atorvastatin Calcium | 32 | $405 |
| Topiramate | 19 | $375 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $155 | $14,13111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 314 adult health providers in Arizona.
Other adult health in Phoenix
- Therese SargentPhoenix$307K
- Natalie WilsonPhoenix$94K
- Kristin StaniszewskiPhoenix$15K
- Stacey GourdouxPhoenix$15K
- Patricia MaybornePhoenix$15K
- Patrick CullenPhoenix$11K
- Doreen YannottaPhoenix$9K
- Quynh VoPhoenix$8K
- Linda StaleyPhoenix$6K
- Angela ToroPhoenix$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.